Human placental lactogen (hPL) is a placental hormone which appears to have key
metabolic functions in pregnancy. Preclinical studies have putatively linked hPL to maternal …

Introduction Maternal metabolic disease states (such as gestational and pregestational
diabetes and maternal obesity) are reaching epidemic proportions worldwide and are …

So far it has not been established which maternal features play the most important role in
newborn macrosomia. The aim of this study is to provide assessment of a hierarchy of twenty …

BACKGROUND Antenatal detection of accelerated fetal growth and macrosomia in
pregnancies complicated by diabetes mellitus is important for patient counseling and …

Aims Pre-gestational diabetes mellitus (PGDM) is associated with adverse outcomes. We
aimed to examine pregnancies affected by PGDM; report on these pregnancy outcomes and …

Background Understanding the risk factors and pregnancy outcomes in women affected by
Type 1 and Type 2 diabetes is important for pre‐pregnancy counselling. Aim To explore …

This study aimed at examining the risk of macrosomia, in relation to maternal pre-pregnancy
overweight/obesity mediated via high maternal triglyceride (mTG) levels. In this prospective …

Aims The mechanism underlying fetal overgrowth during pregnancy remains elusive. We
aimed to establish a predictive model to identify the high-risk individuals with macrosomia in …

Gestational diabetes mellitus (GDM) and large for gestational age (LGA) offspring are two
common pregnancy complications. Connections also exist between the two conditions …

Purpose Fetal macrosomia is associated with perinatal injuries. The purpose of this study
was to assess the relationship between fetal insulin, insulin-like Growth factor-1 (IGF-1), and …